FDA panel votes to approve vaccines for kids

After reviewing Pfizer’s data, the advisory panel voted to support administering the vaccines in children 5 to 11.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting